Introduction.Hepatic steatosis is a reversible condition caused by accumulation oftriglycerides in liver cells. Non-alcoholic fatty liver disease (NAFLD) can progressto advanced liver disease: fibrosis, cirrhosis, liver failure, cancer, and finally canlead to death; therefore NAFLD contributes significantly to morbidity and mortalityof hepatic cause. Materials and methods: The study was conducted on a group of 88patients with Body Mass Index (BMI) ≥ 30kg/m², they were excluded patients withknown diabetes. Results, Discussion: The statistical analysis showed that in morethan half of subjects elastometry values were higher than those considered normal,obesity is a risk factor for NAFLD that progresses in hepatic fibrosis. Conclusions:Liver fibrosis is present in high percentage in patients with obesity (52% of subjects)and it was positively correlated with age, arterial stiffness and fasting glucose.
1. Reddy JK, Rao MS. "Lipid metabolism and liver inflammation. II. Fatty liver disease and fatty acid oxidation". Am. J. Physiol. Gastrointest. Liver Physiol 290 (5): G852-8doi:10.1152, 2005.
2. Adams LA, Angulo P. "Treatment of non alcoholic fatty liver disease". Postgrad Med J 82 (967): 315-22.doi:10.1136, 2006.
3. P. Angulo. Nonalcoholic Fatty Liver Disease: Incidence and Prevalence, GI Epidemiology, lackwell Publishing Ltd, May 2007.
4. Prof. Stefano Bellentani, Epidemiology of NAFLD/NASH in Europe, 36 slide(s) - English - www.multiwebcast.com. 09-25, 2009.
5. Clare Nugent; Zobair M Younossi. Evaluation and Management of Obesity-Related Nonalcoholic Fatty Liver Disease, Nature Clinical Practice Gastroenterology & Hepatology 4(8): 432-441, 2007.
6. Daniel M. Keller. Americans Are Getting Fatter, and So Are Their Livers, European Association for the Study of the Liver (EASL) 46th Annual Meeting.
7. Ziol M, Handra-Luca A, Kettaneh A, Christidis C, Mal F, Kazemi F, de Lédinghen V, Marcellin P, Dhumeaux D, Trinchet JC, Beaugrand M. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology, 41(1): 48-54, 2005.
8. Friedrich-Rust M, Ong MF, Martens S, Sarrazin C, Bojunga J, Zeuzem S, Herrmann E: Performance of transient elastography for the staging of liver fibrosis: a meta-analysis. Gastroenterology 134(4): 960-74. 2008.
9. M Yoneda, K Fujita, M Inamori, A Nakajima, M Yoneda, M Tamano, and H Hiraishi. Transient elastography in patients with non‐alcoholic fatty liver disease (NAFLD), BMJ Publishing Group & British Society of Gastroenterology 2007.
10. Castéra L, Foucher J, Bernard PH, Carvalho F, Allaix D, Merrouche W, Couzigou P, de Lédinghen V. Pitfalls of liver stiffness measurement: a 5-year prospective study of 13,369 examinations. Hepatology 51(3): 828-35, 2010.
11. Manning DS, Afdhal NH: Diagnosis and quantitation of fibrosis. Gastroenterology 134(6): 1670-1681, 2008.
12. Ancha Baranova, Priyanka Lal, Aybike Birerdinc, and Zobair M Younossi, Non-Invasive markers for hepatic fibrosis. BMC Gastroenterol 11: 91, 2011.
13. West J, Card TR. Reduced mortality rates following elective percutaneous liver biopsies. Gastroenterology 139(4): 1230-7, Epub Jun 12, 2010.
15. Vincent Wai-Sun Wong, Julien Vergniol, Grace Lai-Hung Wong, Juliette Foucher, Henry Lik-Yuen Chan,Brigitte Le Bail, Paul Cheung-Lung Choi, Mathurin Kowo, Anthony Wing-Hung Chan, Wassil Merrouche, Joseph Jao-Yiu Sung, and Victor de L´edinghen. Diagnosis of Fibrosis and Cirrhosis Using Liver Stiffness Measurement in Nonalcoholic Fatty Liver Disease, HEPATOLOGY 51: 454-462. 2010.
16. de Lédinghen V, Vergniol J, Foucher J, El-Hajbi F, Merrouche W, Rigalleau V. Feasibility of liver transient elastography with FibroScan using a new probe for obese patients. Liver Int Aug; 30(7), 2010.
17. Hossain N, Afendy A, Stepanova M, Nader F, Srishord M, Rafiq N, Goodman Z, Younossi Z. Independent predictors of fibrosis in patients with nonalcoholic fatty liver disease, Clin Gastroenterol Hepatol Nov; 7(11): 1224-9, 2009.
18. Angulo P, Keach JC, Batts KP, Lindor KD. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology Dec; 30(6): 1356-62. 1999.